First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Hits New 52-Week High – Should You Buy?
by Danessa Lincoln · The Markets DailyFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s share price reached a new 52-week high on Thursday . The stock traded as high as GBX 2,530 and last traded at GBX 2,527, with a volume of 6076 shares changing hands. The stock had previously closed at GBX 2,492.50.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 1.4%
The company has a market cap of £1.04 billion, a P/E ratio of -2,297.27 and a beta of 0.44. The business has a fifty day moving average price of GBX 2,366.55 and a 200-day moving average price of GBX 2,110.18.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.
Featured Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
- Is Palantir Worth $250 or $1? Bulls and Burry Arrive at Opposite Conclusions
- 3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure Builds